Ramasharma Kristipati

Title: Ramasharma Kristipati: Innovator in Neuropathic Pain Solutions

Introduction

Ramasharma Kristipati is a notable inventor based in Fremont, CA (US). He has made significant contributions to the field of neuropathic pain management through his innovative methods and formulations. With a total of 2 patents, Kristipati's work is paving the way for advancements in pain treatment.

Latest Patents

Kristipati's latest patents focus on methods and formulations for preventing the progression of neuropathic pain. One of his key inventions involves administering an N-type voltage-sensitive calcium channel blocking compound. This compound is characterized by its ability to inhibit electrically stimulated contraction of the guinea pig ileum and bind selectively to omega conopeptide MVIIA binding sites present in neuronal tissue. Additionally, he has disclosed formulations that effectively stabilize omega conotoxin peptide preparations at elevated temperatures. Novel omega conopeptides also form part of his inventions.

Career Highlights

Throughout his career, Kristipati has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Neurex Corporation and Elan Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for pain management.

Collaborations

Some of Kristipati's notable coworkers include Gary Arthur Amstutz and Stephen S. Bowersox. Their collaboration has likely fostered an environment of innovation and creativity in their respective fields.

Conclusion

Ramasharma Kristipati's contributions to the field of neuropathic pain management through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in medical treatments for pain relief.